BioStem Technologies (OTCMKTS:BSEM) Posts Quarterly Earnings Results

BioStem Technologies (OTCMKTS:BSEM) announced its quarterly earnings results on Monday. The company reported -0.14 EPS for the quarter, reports. The company had revenue of 11.44 million during the quarter, compared to analyst estimates of 11.40 million.

BioStem Technologies Stock Performance

BSEM traded down 0.74 on Thursday, hitting 13.15. The company had a trading volume of 21,800 shares, compared to its average volume of 28,903. BioStem Technologies has a 1-year low of 1.20 and a 1-year high of 15.50. The stock’s fifty day simple moving average is 8.86.

About BioStem Technologies

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.